Industry and News Fidaxomicin Market Haga clic para leer
  • Comentarios

Industry and News

Fidaxomicin Market

Publicado el en “Negocios, Salud y Estado Físico”, Idioma — English. 4 páginas.
Global Fidaxomicin Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. Fidaxomicin is also termed as Difimicin, or Tiacumicin B, or Lipiarmicin, or Lipiarrmycin, or Lipiarmycin. It is a macrolide antibacterial drug specified for the treatment of Clostridium Difficile-Associated Diarrhea. The antibiotic Fidaxomicin drug kills bacteria in the intestines. Más
Industry And News helps to understand the characteristics and preferences of customers and monitor the level of competition in market. Más
Suscríbase GRATIS

Otras publicaciones de “Industry and News”

Ver todas las publicaciones